Lupus (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lupus" in Uzbek language version.

refsWebsite

Global rank Uzbek rank

110nih.gov

4^th place

7^th place

74doi.org

2^nd place

3^rd place

27web.archive.org

1^st place

9archive.org

6^th place

8^th place

6lupus.org

low place

3books.google.com

3^rd place

4^th place

2rheumatology.org

low place

2fda.gov

447^th place

745^th place

2uptodate.com

3,771^st place

4,073^rd place

1semanticscholar.org

11^th place

82^nd place

1utah.edu

2,446^th place

1,893^rd place

1mayoclinic.com

3,634^th place

2,684^th place

1hopkinslupus.org

low place

1iupui.edu

9,528^th place

low place

1consultantlive.com

low place

1termedia.pl

low place

1uklupus.co.uk

low place

1thefreedictionary.com

614^th place

117^th place

1jrheum.com

low place

1sc.edu

5,559^th place

6,743^rd place

1rochester.edu

2,691^st place

3,515^th place

1wikipedia.org

low place

8,011^th place

1harvard.edu

18^th place

35^th place

1theodora.com

7,749^th place

4,595^th place

1musculoskeletalnetwork.com

low place

1cdc.gov

218^th place

199^th place

1reference.com

657^th place

310^th place

1sciencemag.org

857^th place

2,333^rd place

archive.org

The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families. Baltimore, Maryland: Johns Hopkins University Press, 2014 — 4 bet. ISBN 978-1-4214-0984-9.
The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families. Baltimore, Maryland: Johns Hopkins University Press, 2014 — 463 bet. ISBN 978-1-4214-0984-9.
Coping with Lupus: A Practical Guide to Alleviating the Challenges of Systemic Lupus Erythematosus, 4th, New York, NY: The Penguin Group, 2012 — 11–12 bet. ISBN 978-1-58333-445-4.
Diseases of the skin including the Exanthemata, Vol. 1, London, England: The New Sydenham Society, 1866 — 114–116 bet.
The Lupus Book. New York: Oxford University Press, 1995 — 8 bet. ISBN 978-0-19-508443-6.
Lupus Q&A: Everything you need to know, 2nd, New York, NY: Penguin Group (USA), 2004 — 65–66 bet. ISBN 978-1-58333-196-5.
Coping with Lupus: A Practical Guide to Alleviating the Challenges of Systemic Lupus Erythematosus, 4th, New York, NY: The Penguin Group, 2012 — 24 bet. ISBN 978-1-58333-445-4.
The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families. Baltimore, USA: Johns Hopkins University Press, 2014 — 26 bet. ISBN 978-1-4214-0984-9.
The Lupus Encyclopedia: A Comprehensive Guide for Patients and Families. Baltimore, USA: Johns Hopkins University Press, 2014 — 17–21 bet. ISBN 978-1-4214-0984-9.

books.google.com

The Cleveland Clinic Intensive Review of Internal Medicine, 5, Lippincott Williams & Wilkins, 2012 — 969 bet. ISBN 9781451153309. 13-iyun 2016-yilda qaraldi.
The Language of Medicine. Elsevier Health Sciences, 2013 — 610 bet. ISBN 978-1455728466.
Head and neck manifestations of systemic disease. New York: Informa Healthcare, 2007 — 6 bet. ISBN 9781420017564.

cdc.gov

„OMHD|AMH|Factsheets|Lupus“. 2009-yil 11-yanvarda asl nusxadan arxivlangan. Qaraldi: 2017-yil 15-sentyabr.

consultantlive.com

jmm.consultantlive.com

„Managing neuropsychiatric lupus: Top 10 clinical pearls“. The Journal of Musculoskeletal Medicine. 26-jild, № 4. 2–aprel 2009–yil. 27–aprel 2009–yilda asl nusxadan arxivlandi.{{cite magazine}}: CS1 maint: date format ()

doi.org

Danchenko N, Satia JA, Anthony MS (2006). „Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden“. Lupus. 15-jild, № 5. 308–318-bet. doi:10.1191/0961203306lu2305xx. PMID 16761508. S2CID 6465663.
„Systemic lupus erythematosus“. Lancet. 384-jild, № 9957. November 2014. 1878–1888-bet. doi:10.1016/s0140-6736(14)60128-8. PMID 24881804.
„Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus“. Rheumatology. 56-jild, № suppl_1. April 2017. i100–i113-bet. doi:10.1093/rheumatology/kew417. PMC 5850311. PMID 28375452.
„Effect of gender on clinical presentation in systemic lupus erythematosus“. Rheumatology. 52-jild, № 12. December 2013. 2108–2115-bet. doi:10.1093/rheumatology/ket160. PMID 23641038.
„A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus“. Orphanet Journal of Rare Diseases. 8-jild. January 2013. 2-bet. doi:10.1186/1750-1172-8-2. PMC 3551738. PMID 23289717.
„Systemic lupus erythematosus“. The New England Journal of Medicine. 358-jild, № 9. February 2008. 929–939-bet. doi:10.1056/NEJMra071297. PMID 18305268.
„Gender differences in systemic lupus erythematosus“. Gender Medicine. 1-jild, № 1. August 2004. 12–17-bet. doi:10.1016/S1550-8579(04)80006-8. PMID 16115579.
„Epidemiology and socioeconomic impact of skin disease in lupus erythematosus“. Lupus. 6-jild, № 2. 1997. 96–104-bet. doi:10.1177/096120339700600204. PMID 9061657.
„Osteoarticular tuberculosis in patients with systemic lupus erythematosus“. QJM. 102-jild, № 5. May 2009. 321–328-bet. doi:10.1093/qjmed/hcp015. PMID 19246552.
„Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions“. Arthritis and Rheumatism. 60-jild, № 3. March 2009. 661–668-bet. doi:10.1002/art.24328. PMID 19248111.
„Risk factors of vertebral fractures in women with systemic lupus erythematosus“. Clinical Rheumatology. 28-jild, № 5. May 2009. 579–585-bet. doi:10.1007/s10067-009-1105-3. PMID 19224131. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment“. Annals of the Rheumatic Diseases. 65-jild, № 2. February 2006. 144–148-bet. doi:10.1136/ard.2005.041673. PMC 1798007. PMID 16079164.
„Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus“. Clinical Rheumatology. 28-jild, № 7. July 2009. 841–845-bet. doi:10.1007/s10067-009-1123-1. PMID 19224124. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Systemic lupus erythematosus and accelerated atherosclerosis“. The New England Journal of Medicine. 349-jild, № 25. December 2003. 2379–2380-bet. doi:10.1056/NEJMp038168. PMID 14681501.
„Systemic lupus erythematosus and atherosclerosis: Review of the literature“. Autoimmunity Reviews. 15-jild, № 1. January 2016. 16–21-bet. doi:10.1016/j.autrev.2015.08.007. PMID 26299985.
„Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies“. The Journal of Rheumatology. 40-jild, № 3. March 2013. 273–281-bet. doi:10.3899/jrheum.121048. PMC 4112073. PMID 23378468. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Presentation and prognosis of shrinking lung syndrome in systemic lupus erythematosus: report of four cases“. Rheumatology International. 32-jild, № 5. May 2012. 1391–1396-bet. doi:10.1007/s00296-011-1863-5. PMID 21431288.
„Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis“. The Journal of Rheumatology. 43-jild, № 10. October 2016. 1801–1815-bet. doi:10.3899/jrheum.160041. PMID 27585688. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program“. Arthritis & Rheumatology. 66-jild, № 2. February 2014. 369–378-bet. doi:10.1002/art.38238. PMC 4198147. PMID 24504809. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995“. Archives of Internal Medicine. 160-jild, № 20. November 2000. 3136–3140-bet. doi:10.1001/archinte.160.20.3136. PMID 11074743.
„The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes“. Arthritis and Rheumatism. 42-jild, № 4. April 1999. 599–608-bet. doi:10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F. PMID 10211873.
„Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases“. Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders. 9-jild. 2016. 1–8-bet. doi:10.4137/CMAMD.S37477. PMC 4718090. PMID 26819561.
„Some controversies of neuropsychiatric systemic lupus erythematosus“. Scandinavian Journal of Rheumatology. 31-jild, № 4. 2002. 192–197-bet. doi:10.1080/030097402320318369. PMID 12369649.
„Intracranial hypertension syndrome in systemic lupus erythematosus: clinical analysis and review of the literature“. Journal of Huazhong University of Science and Technology Medical Sciences. 29-jild, № 1. February 2009. 107–111-bet. doi:10.1007/s11596-009-0123-3. PMID 19224175.
„Lupus and the central nervous system“. Current Opinion in Rheumatology. 8-jild, № 5. September 1996. 408–414-bet. doi:10.1097/00002281-199609000-00004. PMID 8941443.
„Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience“. Rheumatology International. 32-jild, № 5. May 2012. 1179–1187-bet. doi:10.1007/s00296-010-1791-9. PMID 21253731.
„Systemic lupus erythematosus and ocular involvement: an overview“. Clinical and Experimental Medicine. 18-jild, № 2. May 2018. 135–149-bet. doi:10.1007/s10238-017-0479-9. PMID 29243035.
„Lupus activity in pregnancy“. Rheumatic Disease Clinics of North America. 33-jild, № 2. May 2007. 237–52, v-bet. doi:10.1016/j.rdc.2007.01.002. PMC 2745966. PMID 17499705.
„A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis“. Clinical Journal of the American Society of Nephrology. 5-jild, № 11. November 2010. 2060–2068-bet. doi:10.2215/CJN.00240110. PMC 3001786. PMID 20688887.
„Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies“. Rheumatology. 41-jild, № 6. June 2002. 643–650-bet. doi:10.1093/rheumatology/41.6.643. PMID 12048290.
„Systemic lupus erythematosus“. BMJ. 332-jild, № 7546. April 2006. 890–894-bet. doi:10.1136/bmj.332.7546.890. PMC 1440614. PMID 16613963.
„Vitamin D and systemic lupus erythematosus: state of the art“. Clinical Rheumatology. 33-jild, № 8. August 2014. 1033–1038-bet. doi:10.1007/s10067-014-2530-5. PMID 24573738.
„An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus“. Scandinavian Journal of Rheumatology. 38-jild, № 4. March 2009. 256–262-bet. doi:10.1080/03009740802552469. PMID 19255932.
„Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese“. Genes and Immunity. 10-jild, № 3. April 2009. 219–226-bet. doi:10.1038/gene.2009.1. PMID 19225526. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis“. Genes and Immunity. 10-jild, № 5. July 2009. 482–486-bet. doi:10.1038/gene.2009.5. PMID 19262578.
„The genetics of SLE: an update in the light of genome-wide association studies“. Rheumatology. 47-jild, № 11. November 2008. 1603–1611-bet. doi:10.1093/rheumatology/ken247. PMID 18611920.
„Recent insights into the genetic basis of systemic lupus erythematosus“. Genes and Immunity. 10-jild, № 5. July 2009. 373–379-bet. doi:10.1038/gene.2009.39. PMC 3144759. PMID 19440199.
„The genetics of systemic lupus erythematosus: putting the pieces together“. Genes and Immunity. 3-jild, № Suppl 1. October 2002. S71–S85-bet. doi:10.1038/sj.gene.6363885. PMID 12215907.
„The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow“. Human Molecular Genetics. 13 Spec No 1-jild, № 90001. April 2004. R143–R148-bet. doi:10.1093/hmg/ddh076. PMID 14764622.
„Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients“. Archives of Dermatology. 115-jild, № 9. September 1979. 1055–1058-bet. doi:10.1001/archderm.1979.04010090005011. PMID 314780.
„Collaboration, genetic associations, and lupus erythematosus“. The New England Journal of Medicine. 358-jild, № 9. February 2008. 956–961-bet. doi:10.1056/NEJMe0800096. PMID 18204099.
„Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX“. The New England Journal of Medicine. 358-jild, № 9. February 2008. 900–909-bet. doi:10.1056/NEJMoa0707865. PMID 18204098. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Systemic lupus erythematosus“. Lancet. 369-jild, № 9561. February 2007. 587–596-bet. doi:10.1016/S0140-6736(07)60279-7. PMID 17307106.
„Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation“. Genes and Immunity. 10-jild, № 5. July 2009. 390–396-bet. doi:10.1038/gene.2009.6. PMID 19262576.
„Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus“. Arthritis and Rheumatism. 46-jild, № 1. January 2002. 175–190-bet. doi:10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H. PMC 4020417. PMID 11817589. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus“. Proceedings of the National Academy of Sciences of the United States of America. 113-jild, № 15. April 2016. E2142–E2151-bet. doi:10.1073/pnas.1513943113. PMC 4839468. PMID 27035940. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus“. Journal of Immunology. 196-jild, № 10. May 2016. 4030–4039-bet. doi:10.4049/jimmunol.1500418. PMC 4868781. PMID 27059595. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis“. Proceedings of the National Academy of Sciences of the United States of America. 107-jild, № 21. May 2010. 9813–9818-bet. Bibcode:2010PNAS..107.9813H. doi:10.1073/pnas.0909927107. PMC 2906830. PMID 20439745. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Mutation of DNASE1 in people with systemic lupus erythematosus“. Nature Genetics. 28-jild, № 4. August 2001. 313–314-bet. doi:10.1038/91070. PMID 11479590.
„Clearance deficiency and systemic lupus erythematosus (SLE)“. Journal of Autoimmunity. 28-jild, № 2–3. 2007. 114–121-bet. doi:10.1016/j.jaut.2007.02.005. PMID 17368845. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus“. Arthritis and Rheumatism. 60-jild, № 3. March 2009. 848–859-bet. doi:10.1002/art.24306. PMC 2653589. PMID 19248110.
„High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus“. Molecular Biology Reports. 37-jild, № 3. March 2010. 1191–1195-bet. doi:10.1007/s11033-009-9485-7. PMID 19247800.
„2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus“. Arthritis & Rheumatology. 71-jild, № 9. September 2019. 1400–1412-bet. doi:10.1002/art.40930. PMC 6827566. PMID 31385462. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach“. Seminars in Arthritis and Rheumatism. 33-jild, № 3. December 2003. 140–154-bet. doi:10.1016/j.semarthrit.2003.09.002. PMID 14671725.
„Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus“. The American Journal of Medicine. 74-jild, № 2. February 1983. 206–216-bet. doi:10.1016/0002-9343(83)90613-7. PMID 6600582.
„Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines“. Lupus. 12-jild, № 7. 2003. 530–534-bet. doi:10.1191/0961203303lu394oa. PMID 12892393. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies“. Annals of the Rheumatic Diseases. 64-jild, № 1. January 2005. 147–148-bet. doi:10.1136/ard.2004.020743. PMC 1755191. PMID 15608315.
„Seronegative antiphospholipid syndrome“. Annals of the Rheumatic Diseases. 62-jild, № 12. December 2003. 1127-bet. doi:10.1136/ard.2003.006163. PMC 1754381. PMID 14644846.
„Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus“. The Cochrane Database of Systematic Reviews. № 2. February 2013. CD002265-bet. doi:10.1002/14651858.cd002265.pub3. PMC 6823222. PMID 23450535.
„BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus“. Immunology and Cell Biology. 90-jild, № 3. March 2012. 293–303-bet. doi:10.1038/icb.2011.111. PMID 22231653.
„Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States“. The Journal of Rheumatology. 48-jild, № 3. March 2021. 385–393-bet. doi:10.3899/jrheum.191187. PMID 32611669. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Cyclophosphamide for treating rheumatoid arthritis“. The Cochrane Database of Systematic Reviews. 2010-jild, № 4. 2000-10-23. CD001157-bet. doi:10.1002/14651858.cd001157. PMC 8407281. PMID 11034702.
„Disease recurrence in paediatric renal transplantation“. Pediatric Nephrology. 24-jild, № 11. November 2009. 2097–2108-bet. doi:10.1007/s00467-009-1137-6. PMC 2753770. PMID 19247694.
„The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus“. European Journal of Rheumatology. 3-jild, № 2. June 2016. 75–84-bet. doi:10.5152/eurjrheum.2015.0085. PMC 5042235. PMID 27708976.
„Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden“. Lupus. 15-jild, № 5. 2006. 308–318-bet. doi:10.1191/0961203306lu2305xx. PMID 16761508.
„SLE mortality remains disproportionately high, despite improvements over the last decade“. Lupus. 27-jild, № 10. September 2018. 1577–1581-bet. doi:10.1177/0961203318786436. PMC 6082727. PMID 30016928.
„Childhood-onset systemic lupus erythematosus: an update“. Current Opinion in Rheumatology. 27-jild, № 5. September 2015. 483–492-bet. doi:10.1097/bor.0000000000000208. PMID 26200474.
„Socioeconomic status in systemic lupus erythematosus“. Lupus. 15-jild, № 11. 2006. 720–723-bet. doi:10.1177/0961203306070008. PMID 17153841.
„Understanding the epidemiology and progression of systemic lupus erythematosus“. Seminars in Arthritis and Rheumatism. 39-jild, № 4. February 2010. 257–268-bet. doi:10.1016/j.semarthrit.2008.10.007. PMC 2813992. PMID 19136143.
„Interactions between patients, providers, and health systems and technical quality of care“. Arthritis Care & Research. 67-jild, № 3. March 2015. 417–424-bet. doi:10.1002/acr.22427. PMC 4320034. PMID 25132660.
„Systemic lupus erythematosus“. The New England Journal of Medicine. 365-jild, № 22. December 2011. 2110–2121-bet. doi:10.1056/NEJMra1100359. PMID 22129255.
„Gender and autoimmunity“. Autoimmunity Reviews. 6-jild, № 6. June 2007. 366–372-bet. doi:10.1016/j.autrev.2006.10.001. PMID 17537382.
„Belimumab for the treatment of systemic lupus erythematosus“. Expert Review of Clinical Immunology. 11-jild, № 2. February 2015. 195–204-bet. doi:10.1586/1744666X.2015.996550. PMID 25543845.

dx.doi.org

„Clearance of apoptotic cells in human SLE“,Apoptosis and Its Relevance to Autoimmunity, Current Directions in Autoimmunity, 2006 — 173–87 bet. DOI:10.1159/000090781. ISBN 978-3-8055-8036-6.

fda.gov

„FDA approves first new lupus drug in 56 years“. Food and Drug Administration. 3-may 2011-yilda asl nusxadan arxivlangan. Qaraldi: 6-may 2011-yil.
„FDA Alert: Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic)“. 16–may 2008–yil. 3–avgust 2010–yilda asl nusxadan arxivlandi. {{cite magazine}}: Cite magazine requires |magazine= (yordam)CS1 maint: date format ()

harvard.edu

ui.adsabs.harvard.edu

„Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis“. Proceedings of the National Academy of Sciences of the United States of America. 107-jild, № 21. May 2010. 9813–9818-bet. Bibcode:2010PNAS..107.9813H. doi:10.1073/pnas.0909927107. PMC 2906830. PMID 20439745. {{cite magazine}}: Invalid |display-authors=6 (yordam)

hopkinslupus.org

„Treating Lupus with Steroids“. Johns Hopkins Lupus Center. Qaraldi: 1-dekabr 2021-yil.

iupui.edu

erl.pathology.iupui.edu

„General Pathology Images for Immunopathology“. 2007-yil 10-mayda asl nusxadan arxivlangan. Qaraldi: 2007-yil 24-iyul.

jrheum.com

„Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support“. The Journal of Rheumatology. 32-jild, № 9. September 2005. 1699–1705-bet. PMID 16142863. 2007-08-16da asl nusxadan arxivlandi.

lupus.org

Joint and Muscle Pain (Wayback Machine saytida 2007-11-09 sanasida arxivlangan) Lupus Foundation of America
„Lupus and women's reproductive health | Lupus Foundation of America“ (en). Lupus Foundation of America. Qaraldi: 1-dekabr 2021-yil.
Robert L. Rubin, Ph.D. „Drug-Induced Lupus Erythematosus“. Lupus Foundation of America. Lupus Foundation of America. 2006-yil 13-oktyabrda asl nusxadan arxivlangan. Qaraldi: 20-iyun 2018-yil.
„Common Symptoms of Lupus“. Lupus Foundation of America. 2013-yil 19-aprelda asl nusxadan arxivlangan. Qaraldi: 7-iyun 2013-yil.
„Prognosis and a Hopeful Future“. Lupus Foundation of America website. 20-mart 2011-yilda asl nusxadan arxivlangan. Qaraldi: 14-dekabr 2010-yil.
Lupus Foundation of America. „What is the history of lupus?“. 4-noyabr 2014-yilda asl nusxadan arxivlangan. Qaraldi: 11-oktabr 2014-yil.

mayoclinic.com

„Lupus: Symptoms — MayoClinic.com“. 2008-yil 14-iyulda asl nusxadan arxivlangan. Qaraldi: 2008-yil 14-iyul.

musculoskeletalnetwork.com

Vasudevan AR, Ginzler EM (4–avgust 2009–yil). „Established and novel treatments for lupus“. The Journal of Musculoskeletal Medicine. 26-jild, № 8.{{cite magazine}}: CS1 maint: date format ()^{[sayt ishlamaydi]}

nih.gov

pubmed.ncbi.nlm.nih.gov

Danchenko N, Satia JA, Anthony MS (2006). „Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden“. Lupus. 15-jild, № 5. 308–318-bet. doi:10.1191/0961203306lu2305xx. PMID 16761508. S2CID 6465663.
„Systemic lupus erythematosus“. Lancet. 384-jild, № 9957. November 2014. 1878–1888-bet. doi:10.1016/s0140-6736(14)60128-8. PMID 24881804.
„Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus“. Rheumatology. 56-jild, № suppl_1. April 2017. i100–i113-bet. doi:10.1093/rheumatology/kew417. PMC 5850311. PMID 28375452.
„Effect of gender on clinical presentation in systemic lupus erythematosus“. Rheumatology. 52-jild, № 12. December 2013. 2108–2115-bet. doi:10.1093/rheumatology/ket160. PMID 23641038.
„A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus“. Orphanet Journal of Rare Diseases. 8-jild. January 2013. 2-bet. doi:10.1186/1750-1172-8-2. PMC 3551738. PMID 23289717.
„Systemic lupus erythematosus“. The New England Journal of Medicine. 358-jild, № 9. February 2008. 929–939-bet. doi:10.1056/NEJMra071297. PMID 18305268.
„Gender differences in systemic lupus erythematosus“. Gender Medicine. 1-jild, № 1. August 2004. 12–17-bet. doi:10.1016/S1550-8579(04)80006-8. PMID 16115579.
„Epidemiology and socioeconomic impact of skin disease in lupus erythematosus“. Lupus. 6-jild, № 2. 1997. 96–104-bet. doi:10.1177/096120339700600204. PMID 9061657.
„Osteoarticular tuberculosis in patients with systemic lupus erythematosus“. QJM. 102-jild, № 5. May 2009. 321–328-bet. doi:10.1093/qjmed/hcp015. PMID 19246552.
„Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions“. Arthritis and Rheumatism. 60-jild, № 3. March 2009. 661–668-bet. doi:10.1002/art.24328. PMID 19248111.
„Risk factors of vertebral fractures in women with systemic lupus erythematosus“. Clinical Rheumatology. 28-jild, № 5. May 2009. 579–585-bet. doi:10.1007/s10067-009-1105-3. PMID 19224131. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Anemia in systemic lupus erythematosus“. The Journal of the Singapore Paediatric Society. 32-jild, № 3–4. 1990. 132–136-bet. PMID 2133750.
„Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment“. Annals of the Rheumatic Diseases. 65-jild, № 2. February 2006. 144–148-bet. doi:10.1136/ard.2005.041673. PMC 1798007. PMID 16079164.
„Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus“. Clinical Rheumatology. 28-jild, № 7. July 2009. 841–845-bet. doi:10.1007/s10067-009-1123-1. PMID 19224124. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Systemic lupus erythematosus and accelerated atherosclerosis“. The New England Journal of Medicine. 349-jild, № 25. December 2003. 2379–2380-bet. doi:10.1056/NEJMp038168. PMID 14681501.
„Systemic lupus erythematosus and atherosclerosis: Review of the literature“. Autoimmunity Reviews. 15-jild, № 1. January 2016. 16–21-bet. doi:10.1016/j.autrev.2015.08.007. PMID 26299985.
„Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies“. The Journal of Rheumatology. 40-jild, № 3. March 2013. 273–281-bet. doi:10.3899/jrheum.121048. PMC 4112073. PMID 23378468. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Presentation and prognosis of shrinking lung syndrome in systemic lupus erythematosus: report of four cases“. Rheumatology International. 32-jild, № 5. May 2012. 1391–1396-bet. doi:10.1007/s00296-011-1863-5. PMID 21431288.
„Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis“. The Journal of Rheumatology. 43-jild, № 10. October 2016. 1801–1815-bet. doi:10.3899/jrheum.160041. PMID 27585688. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program“. Arthritis & Rheumatology. 66-jild, № 2. February 2014. 369–378-bet. doi:10.1002/art.38238. PMC 4198147. PMID 24504809. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995“. Archives of Internal Medicine. 160-jild, № 20. November 2000. 3136–3140-bet. doi:10.1001/archinte.160.20.3136. PMID 11074743.
„The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes“. Arthritis and Rheumatism. 42-jild, № 4. April 1999. 599–608-bet. doi:10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F. PMID 10211873.
„Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases“. Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders. 9-jild. 2016. 1–8-bet. doi:10.4137/CMAMD.S37477. PMC 4718090. PMID 26819561.
„Neurological syndromes in systemic lupus erythematosus and their association with antiphospholipid syndrome“. Neurologia I Neurochirurgia Polska. 42-jild, № 6. 2008. 513–517-bet. PMID 19235104. 2020-01-07da asl nusxadan arxivlandi. Qaraldi: 2022-06-03.
„Some controversies of neuropsychiatric systemic lupus erythematosus“. Scandinavian Journal of Rheumatology. 31-jild, № 4. 2002. 192–197-bet. doi:10.1080/030097402320318369. PMID 12369649.
„Intracranial hypertension syndrome in systemic lupus erythematosus: clinical analysis and review of the literature“. Journal of Huazhong University of Science and Technology Medical Sciences. 29-jild, № 1. February 2009. 107–111-bet. doi:10.1007/s11596-009-0123-3. PMID 19224175.
„Lupus and the central nervous system“. Current Opinion in Rheumatology. 8-jild, № 5. September 1996. 408–414-bet. doi:10.1097/00002281-199609000-00004. PMID 8941443.
„Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience“. Rheumatology International. 32-jild, № 5. May 2012. 1179–1187-bet. doi:10.1007/s00296-010-1791-9. PMID 21253731.
„Systemic lupus erythematosus and ocular involvement: an overview“. Clinical and Experimental Medicine. 18-jild, № 2. May 2018. 135–149-bet. doi:10.1007/s10238-017-0479-9. PMID 29243035.
„Lupus activity in pregnancy“. Rheumatic Disease Clinics of North America. 33-jild, № 2. May 2007. 237–52, v-bet. doi:10.1016/j.rdc.2007.01.002. PMC 2745966. PMID 17499705.
„A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis“. Clinical Journal of the American Society of Nephrology. 5-jild, № 11. November 2010. 2060–2068-bet. doi:10.2215/CJN.00240110. PMC 3001786. PMID 20688887.
„Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies“. Rheumatology. 41-jild, № 6. June 2002. 643–650-bet. doi:10.1093/rheumatology/41.6.643. PMID 12048290.
„Systemic lupus erythematosus“. BMJ. 332-jild, № 7546. April 2006. 890–894-bet. doi:10.1136/bmj.332.7546.890. PMC 1440614. PMID 16613963.
„Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support“. The Journal of Rheumatology. 32-jild, № 9. September 2005. 1699–1705-bet. PMID 16142863. 2007-08-16da asl nusxadan arxivlandi.
„Vitamin D and systemic lupus erythematosus: state of the art“. Clinical Rheumatology. 33-jild, № 8. August 2014. 1033–1038-bet. doi:10.1007/s10067-014-2530-5. PMID 24573738.
„An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus“. Scandinavian Journal of Rheumatology. 38-jild, № 4. March 2009. 256–262-bet. doi:10.1080/03009740802552469. PMID 19255932.
„Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese“. Genes and Immunity. 10-jild, № 3. April 2009. 219–226-bet. doi:10.1038/gene.2009.1. PMID 19225526. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis“. Genes and Immunity. 10-jild, № 5. July 2009. 482–486-bet. doi:10.1038/gene.2009.5. PMID 19262578.
„The genetics of SLE: an update in the light of genome-wide association studies“. Rheumatology. 47-jild, № 11. November 2008. 1603–1611-bet. doi:10.1093/rheumatology/ken247. PMID 18611920.
„Recent insights into the genetic basis of systemic lupus erythematosus“. Genes and Immunity. 10-jild, № 5. July 2009. 373–379-bet. doi:10.1038/gene.2009.39. PMC 3144759. PMID 19440199.
„The genetics of systemic lupus erythematosus: putting the pieces together“. Genes and Immunity. 3-jild, № Suppl 1. October 2002. S71–S85-bet. doi:10.1038/sj.gene.6363885. PMID 12215907.
„The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow“. Human Molecular Genetics. 13 Spec No 1-jild, № 90001. April 2004. R143–R148-bet. doi:10.1093/hmg/ddh076. PMID 14764622.
„Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients“. Archives of Dermatology. 115-jild, № 9. September 1979. 1055–1058-bet. doi:10.1001/archderm.1979.04010090005011. PMID 314780.
„Collaboration, genetic associations, and lupus erythematosus“. The New England Journal of Medicine. 358-jild, № 9. February 2008. 956–961-bet. doi:10.1056/NEJMe0800096. PMID 18204099.
„Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX“. The New England Journal of Medicine. 358-jild, № 9. February 2008. 900–909-bet. doi:10.1056/NEJMoa0707865. PMID 18204098. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Reticulate and stellate acral pigmentation associated with systemic lupus erythematosus and high titers of circulating anticardiolipin antibodies: a possible association with acral microlivedo“. Journal of Drugs in Dermatology. 2-jild, № 6. December 2003. 674–676-bet. PMID 14711150.
„Systemic lupus erythematosus“. Lancet. 369-jild, № 9561. February 2007. 587–596-bet. doi:10.1016/S0140-6736(07)60279-7. PMID 17307106.
„Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation“. Genes and Immunity. 10-jild, № 5. July 2009. 390–396-bet. doi:10.1038/gene.2009.6. PMID 19262576.
„Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus“. Arthritis and Rheumatism. 46-jild, № 1. January 2002. 175–190-bet. doi:10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H. PMC 4020417. PMID 11817589. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus“. Proceedings of the National Academy of Sciences of the United States of America. 113-jild, № 15. April 2016. E2142–E2151-bet. doi:10.1073/pnas.1513943113. PMC 4839468. PMID 27035940. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus“. Journal of Immunology. 196-jild, № 10. May 2016. 4030–4039-bet. doi:10.4049/jimmunol.1500418. PMC 4868781. PMID 27059595. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis“. Proceedings of the National Academy of Sciences of the United States of America. 107-jild, № 21. May 2010. 9813–9818-bet. Bibcode:2010PNAS..107.9813H. doi:10.1073/pnas.0909927107. PMC 2906830. PMID 20439745. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Mutation of DNASE1 in people with systemic lupus erythematosus“. Nature Genetics. 28-jild, № 4. August 2001. 313–314-bet. doi:10.1038/91070. PMID 11479590.
„Clearance deficiency and systemic lupus erythematosus (SLE)“. Journal of Autoimmunity. 28-jild, № 2–3. 2007. 114–121-bet. doi:10.1016/j.jaut.2007.02.005. PMID 17368845. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus“. Arthritis and Rheumatism. 60-jild, № 3. March 2009. 848–859-bet. doi:10.1002/art.24306. PMC 2653589. PMID 19248110.
„High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus“. Molecular Biology Reports. 37-jild, № 3. March 2010. 1191–1195-bet. doi:10.1007/s11033-009-9485-7. PMID 19247800.
„2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus“. Arthritis & Rheumatology. 71-jild, № 9. September 2019. 1400–1412-bet. doi:10.1002/art.40930. PMC 6827566. PMID 31385462. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach“. Seminars in Arthritis and Rheumatism. 33-jild, № 3. December 2003. 140–154-bet. doi:10.1016/j.semarthrit.2003.09.002. PMID 14671725.
„Analysis of the 1982 ARA lupus criteria data set by recursive partitioning methodology: new insights into the relative merit of individual criteria“. The Journal of Rheumatology. 15-jild, № 10. October 1988. 1493–1498-bet. PMID 3060613.
„Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus“. The American Journal of Medicine. 74-jild, № 2. February 1983. 206–216-bet. doi:10.1016/0002-9343(83)90613-7. PMID 6600582.
„Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines“. Lupus. 12-jild, № 7. 2003. 530–534-bet. doi:10.1191/0961203303lu394oa. PMID 12892393. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies“. Annals of the Rheumatic Diseases. 64-jild, № 1. January 2005. 147–148-bet. doi:10.1136/ard.2004.020743. PMC 1755191. PMID 15608315.
„Seronegative antiphospholipid syndrome“. Annals of the Rheumatic Diseases. 62-jild, № 12. December 2003. 1127-bet. doi:10.1136/ard.2003.006163. PMC 1754381. PMID 14644846.
„Is it lupus? The St. Thomas' Hospital "alternative" criteria“. Clinical and Experimental Rheumatology. 16-jild, № 3. 1998. 250–252-bet. PMID 9631744.
„Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus“. The Cochrane Database of Systematic Reviews. № 2. February 2013. CD002265-bet. doi:10.1002/14651858.cd002265.pub3. PMC 6823222. PMID 23450535.
„BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus“. Immunology and Cell Biology. 90-jild, № 3. March 2012. 293–303-bet. doi:10.1038/icb.2011.111. PMID 22231653.
„Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States“. The Journal of Rheumatology. 48-jild, № 3. March 2021. 385–393-bet. doi:10.3899/jrheum.191187. PMID 32611669. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Cyclophosphamide for treating rheumatoid arthritis“. The Cochrane Database of Systematic Reviews. 2010-jild, № 4. 2000-10-23. CD001157-bet. doi:10.1002/14651858.cd001157. PMC 8407281. PMID 11034702.
„Disease recurrence in paediatric renal transplantation“. Pediatric Nephrology. 24-jild, № 11. November 2009. 2097–2108-bet. doi:10.1007/s00467-009-1137-6. PMC 2753770. PMID 19247694.
„The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus“. European Journal of Rheumatology. 3-jild, № 2. June 2016. 75–84-bet. doi:10.5152/eurjrheum.2015.0085. PMC 5042235. PMID 27708976.
„Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden“. Lupus. 15-jild, № 5. 2006. 308–318-bet. doi:10.1191/0961203306lu2305xx. PMID 16761508.
„SLE mortality remains disproportionately high, despite improvements over the last decade“. Lupus. 27-jild, № 10. September 2018. 1577–1581-bet. doi:10.1177/0961203318786436. PMC 6082727. PMID 30016928.
„Childhood-onset systemic lupus erythematosus: an update“. Current Opinion in Rheumatology. 27-jild, № 5. September 2015. 483–492-bet. doi:10.1097/bor.0000000000000208. PMID 26200474.
„Socioeconomic status in systemic lupus erythematosus“. Lupus. 15-jild, № 11. 2006. 720–723-bet. doi:10.1177/0961203306070008. PMID 17153841.
„Understanding the epidemiology and progression of systemic lupus erythematosus“. Seminars in Arthritis and Rheumatism. 39-jild, № 4. February 2010. 257–268-bet. doi:10.1016/j.semarthrit.2008.10.007. PMC 2813992. PMID 19136143.
„Factors associated with health services utilization in patients with systemic lupus erythematosus: a systematic review“. Clinical and Experimental Rheumatology. 28-jild, № 6. Nov–Dec 2010. 892–904-bet. PMID 21122271.
„Interactions between patients, providers, and health systems and technical quality of care“. Arthritis Care & Research. 67-jild, № 3. March 2015. 417–424-bet. doi:10.1002/acr.22427. PMC 4320034. PMID 25132660.
„Systemic lupus erythematosus“. The New England Journal of Medicine. 365-jild, № 22. December 2011. 2110–2121-bet. doi:10.1056/NEJMra1100359. PMID 22129255.
„Gender and autoimmunity“. Autoimmunity Reviews. 6-jild, № 6. June 2007. 366–372-bet. doi:10.1016/j.autrev.2006.10.001. PMID 17537382.
„The history of lupus erythematosus“. Maryland Medical Journal. 40-jild, № 10. October 1991. 871–873-bet. PMID 1943516.
„Belimumab for the treatment of systemic lupus erythematosus“. Expert Review of Clinical Immunology. 11-jild, № 2. February 2015. 195–204-bet. doi:10.1586/1744666X.2015.996550. PMID 25543845.

ncbi.nlm.nih.gov

„Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus“. Rheumatology. 56-jild, № suppl_1. April 2017. i100–i113-bet. doi:10.1093/rheumatology/kew417. PMC 5850311. PMID 28375452.
„A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus“. Orphanet Journal of Rare Diseases. 8-jild. January 2013. 2-bet. doi:10.1186/1750-1172-8-2. PMC 3551738. PMID 23289717.
„Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment“. Annals of the Rheumatic Diseases. 65-jild, № 2. February 2006. 144–148-bet. doi:10.1136/ard.2005.041673. PMC 1798007. PMID 16079164.
„Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies“. The Journal of Rheumatology. 40-jild, № 3. March 2013. 273–281-bet. doi:10.3899/jrheum.121048. PMC 4112073. PMID 23378468. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program“. Arthritis & Rheumatology. 66-jild, № 2. February 2014. 369–378-bet. doi:10.1002/art.38238. PMC 4198147. PMID 24504809. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases“. Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders. 9-jild. 2016. 1–8-bet. doi:10.4137/CMAMD.S37477. PMC 4718090. PMID 26819561.
„Lupus activity in pregnancy“. Rheumatic Disease Clinics of North America. 33-jild, № 2. May 2007. 237–52, v-bet. doi:10.1016/j.rdc.2007.01.002. PMC 2745966. PMID 17499705.
„A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis“. Clinical Journal of the American Society of Nephrology. 5-jild, № 11. November 2010. 2060–2068-bet. doi:10.2215/CJN.00240110. PMC 3001786. PMID 20688887.
„Systemic lupus erythematosus“. BMJ. 332-jild, № 7546. April 2006. 890–894-bet. doi:10.1136/bmj.332.7546.890. PMC 1440614. PMID 16613963.
„Recent insights into the genetic basis of systemic lupus erythematosus“. Genes and Immunity. 10-jild, № 5. July 2009. 373–379-bet. doi:10.1038/gene.2009.39. PMC 3144759. PMID 19440199.
„Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus“. Arthritis and Rheumatism. 46-jild, № 1. January 2002. 175–190-bet. doi:10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H. PMC 4020417. PMID 11817589. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus“. Proceedings of the National Academy of Sciences of the United States of America. 113-jild, № 15. April 2016. E2142–E2151-bet. doi:10.1073/pnas.1513943113. PMC 4839468. PMID 27035940. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus“. Journal of Immunology. 196-jild, № 10. May 2016. 4030–4039-bet. doi:10.4049/jimmunol.1500418. PMC 4868781. PMID 27059595. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis“. Proceedings of the National Academy of Sciences of the United States of America. 107-jild, № 21. May 2010. 9813–9818-bet. Bibcode:2010PNAS..107.9813H. doi:10.1073/pnas.0909927107. PMC 2906830. PMID 20439745. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus“. Arthritis and Rheumatism. 60-jild, № 3. March 2009. 848–859-bet. doi:10.1002/art.24306. PMC 2653589. PMID 19248110.
„2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus“. Arthritis & Rheumatology. 71-jild, № 9. September 2019. 1400–1412-bet. doi:10.1002/art.40930. PMC 6827566. PMID 31385462. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies“. Annals of the Rheumatic Diseases. 64-jild, № 1. January 2005. 147–148-bet. doi:10.1136/ard.2004.020743. PMC 1755191. PMID 15608315.
„Seronegative antiphospholipid syndrome“. Annals of the Rheumatic Diseases. 62-jild, № 12. December 2003. 1127-bet. doi:10.1136/ard.2003.006163. PMC 1754381. PMID 14644846.
„Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus“. The Cochrane Database of Systematic Reviews. № 2. February 2013. CD002265-bet. doi:10.1002/14651858.cd002265.pub3. PMC 6823222. PMID 23450535.
„Cyclophosphamide for treating rheumatoid arthritis“. The Cochrane Database of Systematic Reviews. 2010-jild, № 4. 2000-10-23. CD001157-bet. doi:10.1002/14651858.cd001157. PMC 8407281. PMID 11034702.
„Disease recurrence in paediatric renal transplantation“. Pediatric Nephrology. 24-jild, № 11. November 2009. 2097–2108-bet. doi:10.1007/s00467-009-1137-6. PMC 2753770. PMID 19247694.
„The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus“. European Journal of Rheumatology. 3-jild, № 2. June 2016. 75–84-bet. doi:10.5152/eurjrheum.2015.0085. PMC 5042235. PMID 27708976.
„SLE mortality remains disproportionately high, despite improvements over the last decade“. Lupus. 27-jild, № 10. September 2018. 1577–1581-bet. doi:10.1177/0961203318786436. PMC 6082727. PMID 30016928.
„Understanding the epidemiology and progression of systemic lupus erythematosus“. Seminars in Arthritis and Rheumatism. 39-jild, № 4. February 2010. 257–268-bet. doi:10.1016/j.semarthrit.2008.10.007. PMC 2813992. PMID 19136143.
„Interactions between patients, providers, and health systems and technical quality of care“. Arthritis Care & Research. 67-jild, № 3. March 2015. 417–424-bet. doi:10.1002/acr.22427. PMC 4320034. PMID 25132660.

niams.nih.gov

„Handout on Health: Systemic Lupus Erythematosus“. www.niams.nih.gov (2015-yil fevral). 17-iyun 2016-yilda asl nusxadan arxivlangan. Qaraldi: 12-iyun 2016-yil.
„Handout on Health: Systemic Lupus Erythematosus, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, U.S. Department of Health and Human Services“. 2010-yil 4-dekabrda asl nusxadan arxivlangan. Qaraldi: 2010-yil 13-oktyabr.
„Handout on Health: Systemic Lupus Erythematosus“. The National Institute of Arthritis and Musculoskeletal and Skin Diseases. National Institutes of Health (2003-yil avgust). 2007-yil 18-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2007-yil 23-noyabr.

nlm.nih.gov

„NIM encyclopedic article on the LE cell test“. 2006-yil 6-oktyabrda asl nusxadan arxivlangan.

reference.com

dictionary.reference.com

„Definition in Dictionary.com“. Dictionary.reference.com. 2012-yil 26-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2012-yil 24-oktyabr.

rheumatology.org

„Article on the classification of rheumatic diseases“. Rheumatology.org (2011-yil 8-iyun). 2011-yil 18-iyulda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.
„Revision of Rheumatology.org's diagnostic criteria“. Rheumatology.org (2011-yil 8-iyun). 2011-yil 18-iyulda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.

rochester.edu

urmc.rochester.edu

„Complement C3 (Blood)—Health Encyclopedia—University of Rochester Medical Center“. www.urmc.rochester.edu. 2016-yil 24-sentyabrda asl nusxadan arxivlangan.

sc.edu

pathmicro.med.sc.edu

„University of South Carolina School of Medicine lecture notes, Immunology, Hypersensitivity reactions. General discussion of hypersensitivity, not specific to SLE“. Pathmicro.med.sc.edu (2010-yil 7-iyul). 2011-yil 3-avgustda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.

sciencemag.org

„Genetically engineered immune cells wipe out lupus in mice“ (en). Science | AAAS (6-mart 2019-yil). Qaraldi: 8-may 2019-yil.

semanticscholar.org

api.semanticscholar.org

Danchenko N, Satia JA, Anthony MS (2006). „Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden“. Lupus. 15-jild, № 5. 308–318-bet. doi:10.1191/0961203306lu2305xx. PMID 16761508. S2CID 6465663.

termedia.pl

neurology.termedia.pl

„Neurological syndromes in systemic lupus erythematosus and their association with antiphospholipid syndrome“. Neurologia I Neurochirurgia Polska. 42-jild, № 6. 2008. 513–517-bet. PMID 19235104. 2020-01-07da asl nusxadan arxivlandi. Qaraldi: 2022-06-03.

thefreedictionary.com

medical-dictionary.thefreedictionary.com

thefreedictionary.com > neonatal lupus Citing: Dorland’s Medical Dictionary for Health Consumers. Copyright 2007

theodora.com

„Intravenous Immunoglobulins (IVIGs) in Lupus Central Station, sourced from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, U.S. Department of Health and Human Services“. 2011-yil 20-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2010-yil 13-oktyabr.

uklupus.co.uk

„Lupus site (SLE)“. 2010-yil 29-martda asl nusxadan arxivlangan. Qaraldi: 2009-yil 6-noyabr.

uptodate.com

„Overview of the clinical manifestations of systemic lupus erythematosus in adults“. UpToDate (10-sentabr 2015-yil). 19-aprel 2017-yilda asl nusxadan arxivlangan. Qaraldi: 18-aprel 2017-yil.

patients.uptodate.com

„UpToDate Patient information article on DNA antibodies“. Patients.uptodate.com. 2007-yil 11-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.

utah.edu

healthcare.utah.edu

„Lupus, "The Great Imitator"“. University Health Care. 2009-yil 15-yanvarda asl nusxadan arxivlangan. Qaraldi: 2009-yil 3-fevral.

web.archive.org

„Handout on Health: Systemic Lupus Erythematosus“. www.niams.nih.gov (2015-yil fevral). 17-iyun 2016-yilda asl nusxadan arxivlangan. Qaraldi: 12-iyun 2016-yil.
„Lupus, "The Great Imitator"“. University Health Care. 2009-yil 15-yanvarda asl nusxadan arxivlangan. Qaraldi: 2009-yil 3-fevral.
„Lupus: Symptoms — MayoClinic.com“. 2008-yil 14-iyulda asl nusxadan arxivlangan. Qaraldi: 2008-yil 14-iyul.
„Overview of the clinical manifestations of systemic lupus erythematosus in adults“. UpToDate (10-sentabr 2015-yil). 19-aprel 2017-yilda asl nusxadan arxivlangan. Qaraldi: 18-aprel 2017-yil.
Joint and Muscle Pain (Wayback Machine saytida 2007-11-09 sanasida arxivlangan) Lupus Foundation of America
„General Pathology Images for Immunopathology“. 2007-yil 10-mayda asl nusxadan arxivlangan. Qaraldi: 2007-yil 24-iyul.
„Managing neuropsychiatric lupus: Top 10 clinical pearls“. The Journal of Musculoskeletal Medicine. 26-jild, № 4. 2–aprel 2009–yil. 27–aprel 2009–yilda asl nusxadan arxivlandi.{{cite magazine}}: CS1 maint: date format ()
„Neurological syndromes in systemic lupus erythematosus and their association with antiphospholipid syndrome“. Neurologia I Neurochirurgia Polska. 42-jild, № 6. 2008. 513–517-bet. PMID 19235104. 2020-01-07da asl nusxadan arxivlandi. Qaraldi: 2022-06-03.
„Lupus site (SLE)“. 2010-yil 29-martda asl nusxadan arxivlangan. Qaraldi: 2009-yil 6-noyabr.
„Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support“. The Journal of Rheumatology. 32-jild, № 9. September 2005. 1699–1705-bet. PMID 16142863. 2007-08-16da asl nusxadan arxivlandi.
Robert L. Rubin, Ph.D. „Drug-Induced Lupus Erythematosus“. Lupus Foundation of America. Lupus Foundation of America. 2006-yil 13-oktyabrda asl nusxadan arxivlangan. Qaraldi: 20-iyun 2018-yil.
„University of South Carolina School of Medicine lecture notes, Immunology, Hypersensitivity reactions. General discussion of hypersensitivity, not specific to SLE“. Pathmicro.med.sc.edu (2010-yil 7-iyul). 2011-yil 3-avgustda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.
„Complement C3 (Blood)—Health Encyclopedia—University of Rochester Medical Center“. www.urmc.rochester.edu. 2016-yil 24-sentyabrda asl nusxadan arxivlangan.
„NIM encyclopedic article on the LE cell test“. 2006-yil 6-oktyabrda asl nusxadan arxivlangan.
„Article on the classification of rheumatic diseases“. Rheumatology.org (2011-yil 8-iyun). 2011-yil 18-iyulda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.
„Revision of Rheumatology.org's diagnostic criteria“. Rheumatology.org (2011-yil 8-iyun). 2011-yil 18-iyulda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.
„UpToDate Patient information article on DNA antibodies“. Patients.uptodate.com. 2007-yil 11-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2011-yil 6-avgust.
„Common Symptoms of Lupus“. Lupus Foundation of America. 2013-yil 19-aprelda asl nusxadan arxivlangan. Qaraldi: 7-iyun 2013-yil.
„FDA approves first new lupus drug in 56 years“. Food and Drug Administration. 3-may 2011-yilda asl nusxadan arxivlangan. Qaraldi: 6-may 2011-yil.
„FDA Alert: Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic)“. 16–may 2008–yil. 3–avgust 2010–yilda asl nusxadan arxivlandi. {{cite magazine}}: Cite magazine requires |magazine= (yordam)CS1 maint: date format ()
„Handout on Health: Systemic Lupus Erythematosus, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, U.S. Department of Health and Human Services“. 2010-yil 4-dekabrda asl nusxadan arxivlangan. Qaraldi: 2010-yil 13-oktyabr.
„Intravenous Immunoglobulins (IVIGs) in Lupus Central Station, sourced from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, U.S. Department of Health and Human Services“. 2011-yil 20-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2010-yil 13-oktyabr.
„Handout on Health: Systemic Lupus Erythematosus“. The National Institute of Arthritis and Musculoskeletal and Skin Diseases. National Institutes of Health (2003-yil avgust). 2007-yil 18-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2007-yil 23-noyabr.
„Prognosis and a Hopeful Future“. Lupus Foundation of America website. 20-mart 2011-yilda asl nusxadan arxivlangan. Qaraldi: 14-dekabr 2010-yil.
„OMHD|AMH|Factsheets|Lupus“. 2009-yil 11-yanvarda asl nusxadan arxivlangan. Qaraldi: 2017-yil 15-sentyabr.
Lupus Foundation of America. „What is the history of lupus?“. 4-noyabr 2014-yilda asl nusxadan arxivlangan. Qaraldi: 11-oktabr 2014-yil.
„Definition in Dictionary.com“. Dictionary.reference.com. 2012-yil 26-oktyabrda asl nusxadan arxivlangan. Qaraldi: 2012-yil 24-oktyabr.

wikipedia.org

en.wikipedia.org

„Clearance of apoptotic cells in human SLE“,Apoptosis and Its Relevance to Autoimmunity, Current Directions in Autoimmunity, 2006 — 173–87 bet. DOI:10.1159/000090781. ISBN 978-3-8055-8036-6.